Literature DB >> 8741187

MRI in detection of brain metastases at initial staging of small-cell lung cancer.

M van de Pol1, A G van Oosterhout, J T Wilmink, G P ten Velde, A Twijnstra.   

Abstract

We prospectively investigated 40 patients with small-cell carcinoma of the lung (SCLC) for signs of brain metastasis by neurological examination and MRI of the brain, to determine the significance of MRI for staging. MRI could not be completed in one patient, who was excluded from the study. The MRI studies of the remaining patients showed no abnormalities in 12, cerebral infarcts in 2 and brain metastases in 11 patients, of whom 3 no relevant symptoms. Nonenhancing white matter lesions were found in 14 patients. In 3 of the 4 patients with an abnormal neurological examination at diagnosis, nonenhancing white matter lesions later developed into contrast enhancing lesions compatible with brain metastases; in 2, this occurred during the course of the chemotherapy. MRI did not change the clinical staging in patients with asymptomatic brain metastases.

Entities:  

Mesh:

Year:  1996        PMID: 8741187     DOI: 10.1007/bf00596529

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  14 in total

Review 1.  Management of small-cell cancer of the lung.

Authors:  H H Hansen
Journal:  Lancet       Date:  1992-04-04       Impact factor: 79.321

2.  High-signal foci on MR images of the brain: observer variability in their quantification.

Authors:  F Z Yetkin; V M Haughton; M E Fischer; R A Papke; D L Daniels; L P Mark; L E Hendrix; R J Asleson; J Johansen
Journal:  AJR Am J Roentgenol       Date:  1992-07       Impact factor: 3.959

Review 3.  Small cell carcinoma of the lung: clinical and biologic aspects.

Authors:  J Viallet; D C Ihde
Journal:  Crit Rev Oncol Hematol       Date:  1991       Impact factor: 6.312

4.  The morphologic correlate of incidental punctate white matter hyperintensities on MR images.

Authors:  F Fazekas; R Kleinert; H Offenbacher; F Payer; R Schmidt; G Kleinert; H Radner; H Lechner
Journal:  AJNR Am J Neuroradiol       Date:  1991 Sep-Oct       Impact factor: 3.825

5.  Magnetic resonance signal abnormalities in asymptomatic individuals: their incidence and functional correlates.

Authors:  F Fazekas
Journal:  Eur Neurol       Date:  1989       Impact factor: 1.710

6.  Detection of brain metastases: comparison of contrast-enhanced MR with unenhanced MR and enhanced CT.

Authors:  G Sze; E Milano; C Johnson; L Heier
Journal:  AJNR Am J Neuroradiol       Date:  1990 Jul-Aug       Impact factor: 3.825

7.  Multiple cerebral metastases: detectability with Gd-DTPA-enhanced MR imaging.

Authors:  E J Russell; G K Geremia; C E Johnson; M S Huckman; R G Ramsey; J Washburn-Bleck; D A Turner; M Norusis
Journal:  Radiology       Date:  1987-12       Impact factor: 11.105

8.  Diagnostic value of CT in the detection of brain metastasis in small cell lung cancer patients.

Authors:  J M Habets; A G van Oosterhout; G P ten Velde; J T Wilmink; A Twijnstra
Journal:  J Belge Radiol       Date:  1992-06

9.  Diagnosis of cerebral metastases: double-dose delayed CT vs contrast-enhanced MR imaging.

Authors:  P C Davis; P A Hudgins; S B Peterman; J C Hoffman
Journal:  AJNR Am J Neuroradiol       Date:  1991 Mar-Apr       Impact factor: 3.825

10.  Neurologic disorders in patients with small cell lung cancer.

Authors:  J P Sculier; R Feld; W K Evans; G DeBoer; F A Shepherd; D G Payne; J F Pringle; J L Yeoh; I C Quirt; J E Curtis
Journal:  Cancer       Date:  1987-11-01       Impact factor: 6.860

View more
  5 in total

1.  Brain nodules with lung mass: are they always metastases?

Authors:  Sandra Jorcano; Blanca Farrús; Teresa Pujol; Eugenia Verger; Jordi Marruecos; Carlos Conill
Journal:  Clin Transl Oncol       Date:  2008-08       Impact factor: 3.405

2.  Asymptomatic brain metastases (BM) in small cell lung cancer (SCLC): MR-imaging is useful at initial diagnosis.

Authors:  M M Hochstenbag; A Twijnstra; J T Wilmink; E F Wouters; G P ten Velde
Journal:  J Neurooncol       Date:  2000-07       Impact factor: 4.130

3.  DNA topoisomerase I drugs and radiotherapy for lung cancer.

Authors:  Allan Y Chen; Patricia M T Chen; Yi-Jen Chen
Journal:  J Thorac Dis       Date:  2012-08       Impact factor: 2.895

Review 4.  ACR Appropriateness Criteria® pre-irradiation evaluation and management of brain metastases.

Authors:  Simon Shek-Man Lo; Elizabeth M Gore; Jeffrey D Bradley; John M Buatti; Isabelle Germano; A Paiman Ghafoori; Mark A Henderson; Gregory J A Murad; Roy A Patchell; Samir H Patel; Jared R Robbins; H Ian Robins; Andrew D Vassil; Franz J Wippold; Michael J Yunes; Gregory M M Videtic
Journal:  J Palliat Med       Date:  2014-06-27       Impact factor: 2.947

5.  Cerebral Metastases of Lung Cancer Mimicking Multiple Ischaemic Lesions - A Case Report and Review of Literature.

Authors:  Anna Zacharzewska-Gondek; Hanna Maksymowicz; Małgorzata Szymczyk; Marek Sąsiadek; Joanna Bladowska
Journal:  Pol J Radiol       Date:  2017-09-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.